{"schemaVersion":"peptidescanner-clinical-trials-history-bundle/v1","canonicalUrl":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json","manifestUrl":"https://peptidescanner.com/clinical-trials-history/v1/manifest.json","peptideSlug":"lanreotide","addressing":"objects is keyed by the lower-case NCT number. A URL fragment #<nct number> on this file names one trial's history object.","objectCount":12,"objects":{"nct00565097":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00565097","recordId":"NCT00565097","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00565097-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct00565097","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct00565097"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2007-11-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2007-11-28","publishedAt":"2026-08-23","recordId":"NCT00565097","recordSha256":"cc5a9a496588dd6f861d33fe7a84ba9017c0d2a48b471723b189fb5f0dad6d15","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00565097?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2007-11-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2007-11-30","publishedAt":"2026-08-23","recordId":"NCT00565097","recordSha256":"d7ede17f0733691c7d41e76673ae13a90696a84da825c1847384f269a0fc4f38","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00565097?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2008-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2008-02-12","publishedAt":"2026-08-23","recordId":"NCT00565097","recordSha256":"75690d2e6553e25ed74eea50bab3d2330e11db267edc45e0aa5a54443adcb7d0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00565097?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2009-02-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2009-02-16","publishedAt":"2026-08-23","recordId":"NCT00565097","recordSha256":"af05903b2ba5759da654532d3cfc27fc8f8e577ba268e9ef48e6804ee719c188","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00565097?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"91e2db7f74ce498d091a0410b9a8ad7c8c220e0cfe2570cfdafeded0091aa50f"}},"nct00774930":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT00774930","recordId":"NCT00774930","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00774930-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct00774930","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct00774930"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2008-10-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2008-10-16","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"69919f9457efc572895e69361ac99f862f4f8715e660203f421aae024b2e45b5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2008-10-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2008-10-27","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"1ec908882bc89efa3bb997e26e35a727d1eac79ff1a1af861f2f8ead7c42cf5f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2009-03-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2009-03-20","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"c337184e886fb2b3fe5e3f0bcb0a83b4b7afcfe53ead5f8beffe337e23f96744","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2009-06-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2009-06-25","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"1804fde982e8ae154a7b13f70ab2aaa059cd462aaf2af3f9e23defd4be50d921","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2009-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2009-06-26","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"e7bda35965083e540e7c45eaa28ca2f3aeb3cb5a5c6c79bbe20faf3c76be8106","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2010-03-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-03-09","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"5359117babf1c99f0e79a829e9b6853ee95618f2ad6539e0bbfbfef4a334c563","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Outcome Measures","Sponsor/Collaborators","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2010-04-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-04-29","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"41283b79a27a284573901b6cb1a1e5647c566698cb1d6cdc289625dec45e9b69","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2010-05-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-05-11","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"fc775f6ddff62ac311d5b2266d0de92e3e163f16b5751f52563137850eeb92e5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2010-07-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-07-27","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"d080bdc036186e006caacbc8bbd79e8a994e506a927b77bf5a77a27fefe48de5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2010-11-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2010-11-23","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"51e3d9d223a3bc5c1732d0ebc6268bd3dc422cbc367dc958b1526eed7cfbba94","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2011-02-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-02-28","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"128e2a0b675ac769c37687bc03a2498156a3361f14e803b596bd7534bc26f313","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2011-05-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-05-03","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"14e755de7eb326d787a6f6be327873b5a5f2129db47ee1d5ae2868984c53b23c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Oversight","Study Identification","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2011-06-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-06-08","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"c4dc8611ff296d724e32d9d0afe0fcd3d22bc5d9ec7c5df0cf969f1075eec3ca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Sponsor/Collaborators","Study Description","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2011-10-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-10-20","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"18b9af5efa0d866c5802f18aac7226810d49f575516451e4fe26cd026fd3e2c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2012-01-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-01-30","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"c82012dea8e5e3e0c8e1bb81cb234740f222d4f076b8fc17da800a71f535d74c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2012-04-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-04-30","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"825cd7d749738c7543834398a3b4dee027f7306f380c05ea220c5d3b12efbd34","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2012-05-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-05-28","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"fe51f26550c29fb8ba50e478149f695f066ded69f4f642289c0e8bcf6b02a2b3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2012-07-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-07-30","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"731f13c9b4b8fd68f16c24e9e923e62c37944c6bfaa02295776ef6c10b19f3f8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=18&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Identification","Study Status"],"historyVersion":19,"lastUpdateSubmitQcDate":"2012-10-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-10-02","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"576e0916df1390fc14419285e6e93920dd94b4409129f332af95db8a9a08b292","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=19&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":20,"lastUpdateSubmitQcDate":"2012-10-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-10-30","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"c6d206386bcc85cc2d5b392eeaf4a8a422c64eff295a82c8d6533705c125f25d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=20&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":21,"lastUpdateSubmitQcDate":"2012-12-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2012-12-24","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"b5a761f95acf8e9bd3f74e62cf9eebc9cecec676c4fa1ddcfdddc9e46c7e5364","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=21&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":22,"lastUpdateSubmitQcDate":"2013-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2013-02-26","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"4ab559ba9535776dd5dae0c08aaf689da38d6daf54d444efa786e67af4476eca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=22&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":23,"lastUpdateSubmitQcDate":"2013-08-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2013-08-29","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"1753122be3c62cffc0c474383894202e74114ff7ab45271fede71866185e83cd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=23&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Design","Study Status"],"historyVersion":24,"lastUpdateSubmitQcDate":"2014-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-02-26","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"1b5c29f07bc5ceadb10be0bcfbb8b241260efa4fa038e014923b0775794b7059","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=24&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Eligibility","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Description","Study Status"],"historyVersion":25,"lastUpdateSubmitQcDate":"2016-01-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2016-01-07","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"3b131cf387bbdc3935827c60af376f905de7c519145c9659518e6db36e9195c4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=25&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Conditions","Eligibility","Limitations and Caveats","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","References","Study Description","Study Identification","Study Status"],"historyVersion":26,"lastUpdateSubmitQcDate":"2016-12-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2016-12-28","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"f3d7d7a59ab169f34ccd4835d8c0d3223e4e428423d5e24378784bda3e1150bf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=26&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Baseline Characteristics","Contacts/Locations","Outcome Measures (Results)","Study Status"],"historyVersion":27,"lastUpdateSubmitQcDate":"2019-01-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2019-01-10","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"8e5ca81f25300033dc9d558143f3dfebef55292e2dff5ecf35692d51d0c13944","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=27&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures (Results)","Study Status"],"historyVersion":28,"lastUpdateSubmitQcDate":"2020-11-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2020-11-04","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"8de0fd1d6eac585e0b8fcfe6be0942b3e946f46f3d24783a338cc49ebfd336a0","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=28&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Status"],"historyVersion":29,"lastUpdateSubmitQcDate":"2022-09-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2022-09-15","publishedAt":"2026-08-23","recordId":"NCT00774930","recordSha256":"971d7da3729f445a7b012c43337896eef8080d3c0c0ef7104d1efd8bc02e9d9f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT00774930?a=29&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"bd2c2ef3b5bc3a442f7d4998ee0ddfcda406d5e1fcdce9c638101c10d4b52c7c"}},"nct01354405":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT01354405","recordId":"NCT01354405","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01354405-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct01354405","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct01354405"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2011-05-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2011-05-13","publishedAt":"2026-08-23","recordId":"NCT01354405","recordSha256":"4c7a93e5820bf4afc2ef26f13dd9dbf31b12f41e42aa3662b81b6eeabcaf1779","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01354405?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2013-04-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2013-04-02","publishedAt":"2026-08-23","recordId":"NCT01354405","recordSha256":"6ce510c874bc56ff5ddf1a2b02529f2b7a46af2baaf2cb20865a446171b5a779","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01354405?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2014-07-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2014-07-08","publishedAt":"2026-08-23","recordId":"NCT01354405","recordSha256":"b9b0f1cc3a1562402b502b711c604bb73be270383f6f7bc13b8adb70f803114d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT01354405?a=3&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"8092bb52bb4442ec97c328d14e89ced44f3519a87526d48dfe6230c185811674"}},"nct02075606":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02075606","recordId":"NCT02075606","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02075606-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct02075606","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct02075606"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-02-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-02-27","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"ce7f326d4a748eb157948aa609ae638bad38fdfb871eb6dbe9145f31bca117b8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2014-04-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-04-29","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"a55ec783545af647160e8612250e83bb2f07c5a9fef27251cb7c7ca96453c0fd","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2014-06-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-06-30","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"3ec0a2417d2a5e6a139403840496a44908792287c8f855f1d291f7ac9014b976","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2014-08-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-08-21","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"bbfd589d8c3f3036c24d82d04edceffaa2475e67a40236c6d10a1de85dab984c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Description","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2014-11-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-11-03","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"a2e0153f6b89116be14b8370853543e35d5629056a6e2cf4452d7681c497c5e1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2014-12-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-12-23","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"3c086decdc1c04ca7b95afb1ef3607059942918768fe811953428810b5d420e2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2015-03-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-03-04","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"366295dc69116a1d04cf6e62abb4f3e619b7881106dc0ac2ac764beed0bd6e6c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2015-06-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-06-29","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"2d5af9efb62862619aa0c1d34dc6e306ae7c45d81b9ec5fc3204cfdcc90173d9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2015-09-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-09-29","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"844998dd16711a4d78ebaa454f6cf9430738f64062aaab1d2660c902510d3a2f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2015-12-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-12-21","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"3bdf7f73841996c95fdd5b313d84997bada425ca00de971e150e49a443fdc149","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2016-02-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2016-02-29","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"188d41d79d9a5f2c6e2fba92c5ecf76f92c80f315d00d31b72d008e65c17f49f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2016-04-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2016-04-27","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"7d9c63b34bbfe56ba0a10f266ae61789be59831d2871c20d983771ba6e4f5b81","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2016-05-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2016-05-27","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"769041907bdc6581b54c594aa7d33f7c570241aaf957afc0fda10075b787baed","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2016-08-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2016-08-31","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"b4df21d9ae580c8f0481b6d21e39bccc3efc9a202faa6cd947fecdd0ef284f0d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2016-09-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2016-09-30","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"f9f874f71fc30cbb7753d8df8527ba9b570251e955e55a13d273e79976f6706a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=15&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":16,"lastUpdateSubmitQcDate":"2017-04-07","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-04-07","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"0d2299ec62118e670c8a76dbc3f75c519ffc3bdfd089cbfb8681303cc258c180","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=16&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Identification","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2019-02-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2019-02-28","publishedAt":"2026-08-23","recordId":"NCT02075606","recordSha256":"72c081f616c9be7f471bf6b28b3d55900a7f8dc5d4488adc1b93079f27e47493","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02075606?a=18&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"b1202c669eb07bd34638e095a488ced8237deb4678724b53ec2de3731af003b1"}},"nct02127437":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02127437","recordId":"NCT02127437","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02127437-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct02127437","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct02127437"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2014-04-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2014-04-28","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"78ac31cab0e3a5bd7a9d064399a992207777216cb59f3c2d72f2c43d397ab600","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-02-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-02-02","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"6bb006076c815e0e29db5d9f475574b91417bfa56b80bb0a68fe48088e79b9f1","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2015-11-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-11-11","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"f1a220c30f3da113765d6ccf576e72ee83c9b50f1e369f65d8ae1bb64fd90342","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2016-08-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2016-08-25","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"c92c4584285d54a7d3d4b323e09a3052a9d92bd5a1126930026ad00d3c00970b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-11-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-11-22","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"9a13a6b22f7b0ddee4cf96b99ea0569acf931ba37085eb41dbe03259ca0d7ded","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2017-12-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-12-20","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"025f60772350ff6c58b7d0f1f93d9f0824a7184df11cf72dcc1c32a3532862c8","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2019-11-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2019-11-15","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"cdd2fb982bb4c1e6df862d03b70bc45984c9184f26cd5a9e7fcf0664300b5b8b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Sponsor/Collaborators","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2026-04-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2026-04-02","publishedAt":"2026-08-23","recordId":"NCT02127437","recordSha256":"d3ba73e5cb8c3e6c46b8d690cb541522082c3b1d73797fa5deb6e824a96c3351","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02127437?a=8&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"90ed20c756972bffc2d00f2a6a4644c2e8c124e49ffdbdf201cd330e048c5074"}},"nct02351128":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02351128","recordId":"NCT02351128","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02351128-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct02351128","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct02351128"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-01-29","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"fd04edc5789c7210f5e7c86aa9bd4d1c52dc4de102c0d4a6b793b1c84f02636d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2015-08-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2015-08-11","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"bbdc02dcc1326c9f4fc5fa94884fd9053fcaf46d0ae1becf77ccac53280b2fd5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2016-05-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2016-05-31","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"80045bd450d55b79877b056417aea132c8fc509e11e2316dde4e43f44156e4b5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2017-02-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-02-21","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"6f7745417814008a5f899740884a22eda0f1a323fcb695b03b2caff10ffb50ea","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2017-10-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2017-10-17","publishedAt":"2026-08-23","recordId":"NCT02351128","recordSha256":"192f209863033916afa6d00b5b75cdcc7f615d4d4582096cc08d8d89dfb99e1e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02351128?a=5&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"2f30075160177bf2be42f2def9dc7a26742deb94a25eb5f8c063e37daf448619"}},"nct03012594":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03012594","recordId":"NCT03012594","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03012594-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct03012594","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct03012594"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-01-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-01-04","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"478452439ff03903c64bf8f753738424f8c5eff0a2388de091333d9c1a1f0307","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Outcome Measures","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-01-13","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-01-13","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"d3eba984f7fe86f1fbb771a1de96161360a4c1bbcd73e0cf6a2449d772fa0b42","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-02-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2018-02-05","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"82b5756e1824a05d85453ff90a336c4e34790d78e3068b352f1bd82475477897","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2019-02-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2019-02-18","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"330cfeb10d11654521eb9c16f407e0ad528d72c56c4a08c81073900a93d10e93","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Baseline Characteristics","Contacts/Locations","Document Section","Eligibility","Limitations and Caveats","More Information","Outcome Measures","Outcome Measures (Results)","Oversight","Participant Flow","Sponsor/Collaborators","Study Design","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2020-12-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2020-12-23","publishedAt":"2026-08-23","recordId":"NCT03012594","recordSha256":"41f4e13a4de6d11bb86f8895566356abf7bcc345d00c4ae6c5c0a0798a2c98f2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03012594?a=6&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"1e9daffd23e2c983c44b6fd6a97564aad31a6e959ff1c77b3f58ccb905d7915b"}},"nct03043664":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03043664","recordId":"NCT03043664","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03043664-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct03043664","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct03043664"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-02-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-02-02","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"3f29a01cc6ba9a1c36f31729af10663e34d36360dc837cf154812e3aaac93a1c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-05-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-05-23","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"f91f444ce8e1c21b5e340b092ee742c2e7a933ba1edabf297a4ff90a2f6b5967","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-07-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-07-31","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"d7eef93ab5337c9951e722015882728f0a4bb046a1af3fe1e95abd7939a0feaf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-06-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2018-06-11","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"af512e8c164c5c0f4aaecf0b4df9cb97649cc9fe7e53325d0244090b25c06ebb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2019-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2019-06-26","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"1b70343b420d421d561a573cdff78deeb068d72c754b2a5b287d9e2e4a353236","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-07-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2019-07-03","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"e822106c30bdfbeee62cd2fea026eebb097f57afadc6fc10e0c6d12f57dd5c9b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2020-01-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-01-10","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"7aacb350957ee1c3bb3a31c3d83e63b4812925beaaadbf4d25c405d2ef5ce6be","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2020-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"SUSPENDED","peptideSlug":"lanreotide","submittedDate":"2020-02-12","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"3fae638bac4376af2e29ea77c7ea1408ce1d82e75943b1459046fe9da2f59787","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2020-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-04-03","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"d603e9ce8c5ac168d650303bc1619d743d2179ab58083283546f122f69ab3475","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2020-07-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-07-02","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"5627559671a21167de32995a4dacc3dc33855b4f6ae06cdd9ec202d426773e4d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2020-11-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-11-10","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"6dd7868162675069af53128aee777fbbcd124ad7c18afcfa9b95975c7ec7dfa2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2021-04-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-04-28","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"f0c9caf396ca17f58b5a49060357db206fd21641f3fe3884ffe66927bc28389f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2021-07-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-07-01","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"8641c8d11ef8e1f650a2c9e8bf46ccd01f6aaff4534e17ac4eb107c49a964ff3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2021-10-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-10-01","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"850430e1f8dd082c12cb5e016b0d1a3d9622f25c61bc1a56b494abeada3d5118","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2022-09-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2022-09-01","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"d676697a98bfec74f7439a6db217714ae4c840ccfd55554b961a7d61922791cf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2023-06-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2023-06-12","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"6b663648cf73ded15d45ecf1239f13617d5a32a4fe18e10421f65441406e6f10","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=18&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"077f8f3eb3ee1df5b7bf25db130964c6e29c855310244bb1acc02ba03fbb93bf"}},"nct03158090":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03158090","recordId":"NCT03158090","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03158090-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct03158090","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct03158090"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-05-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-05-16","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"756aacdb058f3b32594d02c26606d376ba406353278ea81a592002eb5e12852f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=1&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-05-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-05-22","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"fa3127d1fb99b72f548da6f71b20c7a5b510a192b5f5d5f68442bbca6016980d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=2&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2018-05-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2018-05-31","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"be4a5919b993596b370977f74c8286d2de9499431643edf6e6e68dbce6c2d50c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=3&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-05-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-05-28","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"f742cfd66af1d7e75a8fc1609208d91af163f261fc0f0b28a0b5fcb4334e9904","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=4&tab=history","studyType":"OBSERVATIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2022-03-14","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2022-03-14","publishedAt":"2026-08-23","recordId":"NCT03158090","recordSha256":"e8e8afa816917001a8645372863a2d035c18b626c57990fd79e2fef89bd2ee98","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03158090?a=5&tab=history","studyType":"OBSERVATIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"f1f04b2f4a428e9af2199345bc9b434d4810c03fdc27c62bc46824f862461c59"}},"nct03946527":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03946527","recordId":"NCT03946527","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03946527-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct03946527","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct03946527"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2019-05-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2019-05-09","publishedAt":"2026-08-23","recordId":"NCT03946527","recordSha256":"c120e3e4ee9651657dbbe4e176830f184d42022e12255896bd39792ee9f8211f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03946527?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2021-10-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-10-06","publishedAt":"2026-08-23","recordId":"NCT03946527","recordSha256":"66794bf490f43f62af313c80ea22a3ea5cb2f7c779a7173d101b75e9a17d201c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03946527?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2021-11-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-11-17","publishedAt":"2026-08-23","recordId":"NCT03946527","recordSha256":"b46d56678a18448822fe81da2ed0aa53bd14d9eb9b7d20aba6a4f7f3cf737377","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03946527?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2022-10-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2022-10-05","publishedAt":"2026-08-23","recordId":"NCT03946527","recordSha256":"cfd1971c407af390712c1cf5de2346db9dd200b39aadf4de7629c210591b5e1c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03946527?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2025-02-26","publishedAt":"2026-08-23","recordId":"NCT03946527","recordSha256":"d8a95b587806a54de2fae7b8d7db9a94b9f10236340f0fd52c6d01b7e0e6cc67","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03946527?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2026-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2026-02-26","publishedAt":"2026-08-23","recordId":"NCT03946527","recordSha256":"f43277da0af127a5abef25d338fa3eee528124559e84d58fa1294a44a2043b7c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03946527?a=6&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"8f8d0c26c13300137593c1fbcfce3651b802e40abe261eddad76f66ca45fcd97"}},"nct05048901":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT05048901","recordId":"NCT05048901","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05048901-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct05048901","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct05048901"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2021-09-09","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-09-09","publishedAt":"2026-08-23","recordId":"NCT05048901","recordSha256":"bfff73ecf0f849ca0662ee49e0acbd25e89bba7f0eca661651eafc601275cfc3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05048901?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Sponsor/Collaborators","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2023-04-05","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2023-04-05","publishedAt":"2026-08-23","recordId":"NCT05048901","recordSha256":"f580ed1c1c50345b14270910d9ca05c1f735c191008989c156a06914560c4ce4","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05048901?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2024-07-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2024-07-02","publishedAt":"2026-08-23","recordId":"NCT05048901","recordSha256":"de4cec0ba70c7c15089b1252b9b799611d16116ea06f358a2eeade35e47e7786","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05048901?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-04-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2026-04-06","publishedAt":"2026-08-23","recordId":"NCT05048901","recordSha256":"4986a1623b42b8a4e9fe5b117391c4b2fe0abea042cba309c4a868e506e66c35","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05048901?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"0d063165ffc8354fe495b755abfb48c6a731b690b85383e84a4e6b8a5ef3b55a"}},"nct06807437":{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT06807437","recordId":"NCT06807437","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06807437-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.json#nct06807437","markdown":"https://peptidescanner.com/clinical-trials-history/v1/peptides/lanreotide.md#nct06807437"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2025-01-29","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2025-01-29","publishedAt":"2026-08-23","recordId":"NCT06807437","recordSha256":"90ef589f27665f1a880b9a2e41cf517abee4d2c6fe4600cbe687002e072848db","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06807437?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2025-08-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2025-08-12","publishedAt":"2026-08-23","recordId":"NCT06807437","recordSha256":"1d9fef3661a97b7fa396ddf2e252635eefa002b84cd23b54af1790fe1a0520ca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06807437?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2025-09-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2025-09-08","publishedAt":"2026-08-23","recordId":"NCT06807437","recordSha256":"fef1835a162d9694e0b30f11d8b8bfe759dd74e2346859827ab1ca8dde076e09","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06807437?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2025-10-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2025-10-06","publishedAt":"2026-08-23","recordId":"NCT06807437","recordSha256":"7a3282dcb1b9273b4519d3f48daefaff622bab91655f5df5efd2bae2db71b38b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06807437?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2025-12-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2025-12-04","publishedAt":"2026-08-23","recordId":"NCT06807437","recordSha256":"3893ce6aa97b59504c892648f4631382ef9e1e11b2eef5d757e57b269db8bb8c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06807437?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2026-03-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2026-03-25","publishedAt":"2026-08-23","recordId":"NCT06807437","recordSha256":"6e96fe348412bd22f328d917247a126596202495b27c9d1652296cf4ad1f2dca","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT06807437?a=6&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"1cb4b4d8cea77b15d3c99aa1f14c2f6bfd30e860020a244ff646a861f26be006"}}}}
